CommercialJuly 1, 2021
Designated specialty pharmacy network updates
This update is to advise of the following changes:
Effective for dates of service on and after October 1, 2021, the following specialty pharmacy medications will be added to the Designated Medical Specialty Pharmacy drug list. Accordingly, hospitals that are not in the Designated Specialty Pharmacy Network will be required to acquire these specialty medications administered in the hospital outpatient setting from CVS Specialty Pharmacy.
HCPCS |
Description |
Brand Name |
Q5117 |
INJECTION, TRASTUZUMAB-ANNS, BIOSIMILAR 10MG |
Kanjinti |
J1558 |
INJECTION, IMMUNE GLOBULIN 100MG |
Xembify |
Q5123 |
INJECTION, RITUXIMAB-ARRX, BIOSIMILAR |
Riabni |
To access the current Designated Medical Specialty Pharmacy drug list, please visit anthem.com, select Providers, select Forms and Guides (under the Provider Resources column), select Georgia, scroll down and select Pharmacy in the Category drop down. The Designated Medical Specialty Pharmacy drug list may be updated periodically by Anthem.
If you have questions or would like to discuss the terms and conditions to be included as a Designated Specialty Pharmacy Network provider, please contact your local Anthem network consultant. Thank you for your continued participation in the Anthem networks and the services you provide to our members.
PUBLICATIONS: July 2021 Anthem Provider News - Georgia
To view this article online:
Or scan this QR code with your phone